Arkolith/Insider Trading/AORT/Form 4

Stanton Marshall S.

SVP, Clinical & MD AffairARTIVION, INC. (AORT) · full profile →Form 4 · filed Nov 24, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.1M
Net Open-Market Flow
-$2.1M
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 21, 2025Sell(S)19K$44.91$840K53K
Nov 21, 2025Sell(S)8K$45.35$380K45K
Nov 21, 2025Option exercise(M)20K$18.44$374K65K
Nov 21, 2025Sell(S)15K$44.92$655K50K
Nov 21, 2025Sell(S)6K$45.35$259K45K
Nov 21, 2025Option exercise(M)27K$11.03$299K72K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 21, 2025Option exercise(M)20K—$00
Nov 21, 2025Option exercise(M)27K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-25-053859) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML